Dr Nikolai Petrovsky | Chairman
Vaxine Pty.
Nikolai Petrovsky is Professor of Medicine at Flinders University and founder of Vaxine Pty Ltd. Known internationally for his vaccine adjuvant research he has held several large Adjuvant Development contracts from the U.S. National Institutes of Health. His research has won many awards including the 2010 Ernst & Young Entrepreneur of the Year Award, 2011 BioSpectrum Asia-Pacific Emerging Company of the Year Award, a 2011 Vaccine Industry Excellence Award for Most Innovative Asian Biotech and 2013 Biopharma Asia, Asian Executive of the Year Award. He has taken multiple vaccines, including for influenza, hepatitis B and allergy from the bench to the clinic and has authored over 100 research papers.
Appearances:
Pre-congress Workshops, April 6 @ 10:00
WORKSHOP B (FULL DAY): ANIMAL HEALTH
AM: SCIENTIFIC ADVANCEMENTS IN THE COMPANION ANIMAL CANCER VACCINE SPACEWorkshop Leader: Philip J. Bergman- Overcoming current limitations in selecting immunogenic neoantigens
- Bridging the gap between human and animal cancer: translational studies of a polyvalent cancer preventative vaccine
- Personalized autologous cancer vaccine for cats & dogs
- Development of an animal health vaccine using gene-based checkpoint inhibitors
- The safety of an adjuvanted autologous cancer vaccine platform in canine cancer patients
- From treating veterinary cancers to launching a first-in-human clinical trial
Pre-congress Workshops, April 6 @ 2:00
WORKSHOP I (AFTERNOON ONLY): VACCINE TECHNOLOGY
Breakthrough vaccine technologiesNew technologies in vaccinology have become a much-anticipated field over the years with increasingly more preclinical and clinical staged developments. This workshop focuses on recent advances and their application in providing protection against infectious diseases to improve immunogenicity of vaccines and understanding the immune response.Presentation include:- Technologies that are transforming vaccinology
- Development of the first human vaccine created solely by artificial intelligence
- Optimizing High Parameter Caytometry for Large Cohort Analysis
- Applications of structural bioinformatics in vaccine design
- Structural based antigen design in industry
last published: 05/Mar/20 10:35 GMT
Sign Up for Event Updates
Organiser
